You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,887,845


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,887,845
Title:Antiviral compositions
Abstract:The present invention is concerned with pharmaceutical compositions of antiviral compounds which can be administered to a mammal, in particular a human, suffering from a viral infection. These compositions comprise particles obtainable by melt-extruding a mixture comprising one or more antiviral compounds and one or more appropriate water-soluble polymers and subsequently milling said melt-extruded mixture.
Inventor(s): Verreck; Geert (Malle, BE), Baert; Lieven (Brugge 2, BE)
Assignee: Janssen Pharmaceutica NV (BE)
Application Number:11/347,071
Patent Claim Types:
see list of patent claims
Compound; Formulation; Composition; Dosage form; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,887,845

Introduction

United States Patent 7,887,845, titled "Antiviral compositions," is a patent that covers pharmaceutical compositions of antiviral compounds. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The patent, issued to cover antiviral compositions, is specifically designed for administration to mammals, particularly humans. It involves various chemical compounds and formulations aimed at treating viral infections[4][5].

Scope of the Patent

The scope of a patent is defined by its claims, which outline the specific inventions or innovations that are protected.

Claim Structure

The claims in Patent 7,887,845 are structured to cover various aspects of the antiviral compositions, including:

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For example, Claim 1 might describe the overall composition, while subsequent claims might narrow down to specific components or methods of preparation[4].
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. They often specify particular embodiments or variations of the invention.

Claim Language and Metrics

Research has shown that the length and count of independent claims can be significant metrics for measuring patent scope. Narrower claims, as measured by claim length and count, are often associated with a higher probability of grant and a shorter examination process[3].

Claims Analysis

The claims in Patent 7,887,845 can be analyzed based on several key components:

Chemical Compounds

The patent claims cover a variety of chemical compounds, including:

  • Benzonitrile and Pyrimidinyl Derivatives: These are central to the antiviral activity of the compositions.
  • Amino and Cyano Groups: These functional groups are integral to the chemical structure of the compounds.
  • Pharmaceutical Excipients: The claims also include various excipients such as hydroxypropyl methyl cellulose, sodium salts, and other substances that aid in the formulation of the antiviral compositions[4].

Formulations and Methods

The patent covers different forms of the antiviral compositions, including:

  • Solid Dispersions: Methods for preparing solid dispersions of the antiviral compounds.
  • Aqueous Solutions: Formulations involving aqueous solutions of the compounds.
  • Dosage Forms: Claims include various dosage forms such as tablets, capsules, and oral suspensions[4].

Patent Landscape

Understanding the broader patent landscape is crucial for assessing the uniqueness and potential impact of Patent 7,887,845.

Prior Art and Citations

The Common Citation Document (CCD) application, which consolidates prior art cited by multiple patent offices, can be useful in identifying relevant prior art. This helps in understanding how the claims of Patent 7,887,845 differentiate from existing inventions[1].

International Patent Offices

The patent landscape extends beyond the U.S. patent system. Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) can be searched to see if similar inventions have been patented abroad. This is particularly important for pharmaceutical compositions, which often have global market implications[1].

Competing Patents

Identifying competing patents in the antiviral field involves searching through databases like PATENTSCOPE and national patent offices. This helps in understanding the competitive landscape and potential overlaps or distinctions between different patents[1].

Search Tools and Resources

Several tools and resources are available for conducting a thorough search of the patent landscape:

USPTO Resources

  • Patent Public Search: A modern web-based tool that replaces legacy search tools and provides enhanced access to prior art.
  • Global Dossier: Allows users to view the patent family for a specific application, including related applications filed at participating IP offices.
  • Patent and Trademark Resource Centers (PTRCs): Local resources that offer training in patent search techniques and access to local search resources[1].

International Databases

  • European Patent Office (EPO) - esp@cenet: Provides access to Europe's patent databases and machine translations of European patents.
  • Japan Patent Office (JPO): Offers machine translations of Japanese patents.
  • World Intellectual Property Organization (WIPO) - PATENTSCOPE: Features a full-text search of published international patent applications and machine translations for some documents[1].

Key Takeaways

  • Claims Structure: The patent's claims are structured to cover a range of antiviral compositions and formulations.
  • Chemical Compounds: The patent focuses on specific chemical compounds and their functional groups.
  • Formulations and Methods: Various dosage forms and preparation methods are covered.
  • Patent Landscape: Understanding prior art, international patents, and competing patents is crucial for assessing the patent's uniqueness and impact.
  • Search Tools: Utilizing USPTO resources and international databases is essential for a comprehensive patent search.

FAQs

  1. What is the main focus of United States Patent 7,887,845?

    • The main focus is on pharmaceutical compositions of antiviral compounds for administration to mammals, particularly humans.
  2. How are the claims structured in this patent?

    • The claims are structured into independent and dependent claims, with independent claims defining the broadest scope and dependent claims providing additional details.
  3. What are some key chemical compounds covered by this patent?

    • The patent covers benzonitrile and pyrimidinyl derivatives, amino and cyano groups, and various pharmaceutical excipients.
  4. What resources can be used to search the patent landscape for similar inventions?

    • Resources include the USPTO's Patent Public Search, Global Dossier, and international databases like esp@cenet, JPO, and PATENTSCOPE.
  5. Why is it important to analyze the scope and claims of a patent?

    • Analyzing the scope and claims helps in understanding the protected invention, identifying potential overlaps with other patents, and assessing the patent's impact and uniqueness.

Sources

  1. USPTO - Search for patents
  2. USA.gov - U.S. Patent and Trademark Office (USPTO)
  3. SSRN - Patent Claims and Patent Scope
  4. Google Patents - US7887845B2 - Antiviral compositions
  5. DrugPatentWatch - Patent 7,887,845

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,887,845

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,887,845

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
99203128Sep 24, 1999

International Family Members for US Patent 7,887,845

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 1636 ⤷  Subscribe
African Regional IP Organization (ARIPO) 1639 ⤷  Subscribe
Argentina 021137 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.